Detalles de la búsqueda
1.
Using clinical and radiomic feature-based machine learning models to predict pathological complete response in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation.
Eur Radiol
; 33(12): 8554-8563, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439939
2.
A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
BMC Cancer
; 20(1): 1190, 2020 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33276753
3.
Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
BMC Pulm Med
; 19(1): 98, 2019 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118007
4.
Outcomes of SBRT for lung oligo-recurrence of non-small cell lung cancer: a retrospective analysis.
J Radiat Res
; 63(2): 272-280, 2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34958672
5.
A propensity-matched analysis of stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: the results in a Chinese population.
J Thorac Dis
; 13(3): 1822-1832, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33841971
6.
Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer.
Transl Lung Cancer Res
; 9(4): 1472-1482, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32953519
7.
Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease.
Transl Lung Cancer Res
; 9(6): 2328-2336, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33489796
8.
Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.
Ann Transl Med
; 8(20): 1310, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33209890
9.
The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer.
Transl Lung Cancer Res
; 9(3): 713-721, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676333
10.
High PD-L1 expression is associated with a favorable prognosis in patients with esophageal squamous cell carcinoma undergoing postoperative adjuvant radiotherapy.
Oncol Lett
; 17(2): 1626-1634, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675222
11.
ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients.
Radiat Oncol
; 14(1): 192, 2019 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31684999
12.
DUSP1 enhances the chemoresistance of gallbladder cancer via the modulation of the p38 pathway and DNA damage/repair system.
Oncol Lett
; 16(2): 1869-1875, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30008878
13.
Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer.
J Cancer
; 6(11): 1172-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26516366
14.
Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma.
Oncol Lett
; 9(1): 257-261, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25435970
Resultados
1 -
14
de 14
1
Próxima >
>>